Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin A Ezekowitz

Showing results (31-40 of 395) with videos related to

Pageof 40
Sort By:
Annals of Internal Medicine|May 20, 2009
ACP Journal Club. Irbesartan did not reduce all-cause death or CV hospitalization in heart failure and preserved ejection fractionJustin A Ezekowitz, Finlay A McAlister
Circulation. Cardiovascular Quality and Outcomes|June 21, 2017
Multitype Events and the Analysis of Heart Failure Readmissions: Illustration of a New Modeling Approach and Comparison With Familiar Composite End PointsPaul M Brown, Justin A Ezekowitz
Circulation. Cardiovascular Quality and Outcomes|June 4, 2018
Examining the Influence of Component Outcomes on the Composite at the Design StagePaul M Brown, Justin A Ezekowitz
European Journal of Heart Failure|January 5, 2017
Diabetes and heart failure in the crosshairs: where is the target?Justin A Ezekowitz, Paul W Armstrong
The Canadian Journal of Cardiology|February 26, 2014
Risk stratification in acute heart failureDouglas S Lee, Justin A Ezekowitz
Circulation. Heart Failure|January 13, 2017
Composite End Points in Clinical Trials of Heart Failure Therapy: How Do We Measure the Effect Size?Paul M Brown, Justin A Ezekowitz
Nutrition (Burbank, Los Angeles County, Calif.)|July 13, 2015
Re. "Dietary fatty acids intake and mortality in patients with heart failure": Authors' responseEloisa Colin-Ramirez, Justin A Ezekowitz
Circulation|April 12, 2017
Letter by Brown and Ezekowitz Regarding Article, "Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective"Paul M Brown, Justin A Ezekowitz
The Canadian Journal of Cardiology|November 13, 2024
The "Small" Clinical Trial: Methods, Analysis, and Interpretation in Acute Care CardiologyFernando G Zampieri, Justin A Ezekowitz
JACC. Heart Failure|April 30, 2021
Reply: Optimal Positioning of Novel Heart Failure Pharmacotherapies: The Case of VericiguatPaul W Armstrong, Justin A Ezekowitz
Pageof 40

Showing results (31-40 of 395) with videos related to

Sort By:
Pageof 40
Annals of Internal Medicine|May 20, 2009
ACP Journal Club. Irbesartan did not reduce all-cause death or CV hospitalization in heart failure and preserved ejection fractionJustin A Ezekowitz, Finlay A McAlister
Circulation. Cardiovascular Quality and Outcomes|June 21, 2017
Multitype Events and the Analysis of Heart Failure Readmissions: Illustration of a New Modeling Approach and Comparison With Familiar Composite End PointsPaul M Brown, Justin A Ezekowitz
Circulation. Cardiovascular Quality and Outcomes|June 4, 2018
Examining the Influence of Component Outcomes on the Composite at the Design StagePaul M Brown, Justin A Ezekowitz
European Journal of Heart Failure|January 5, 2017
Diabetes and heart failure in the crosshairs: where is the target?Justin A Ezekowitz, Paul W Armstrong
The Canadian Journal of Cardiology|February 26, 2014
Risk stratification in acute heart failureDouglas S Lee, Justin A Ezekowitz
Circulation. Heart Failure|January 13, 2017
Composite End Points in Clinical Trials of Heart Failure Therapy: How Do We Measure the Effect Size?Paul M Brown, Justin A Ezekowitz
Nutrition (Burbank, Los Angeles County, Calif.)|July 13, 2015
Re. "Dietary fatty acids intake and mortality in patients with heart failure": Authors' responseEloisa Colin-Ramirez, Justin A Ezekowitz
Circulation|April 12, 2017
Letter by Brown and Ezekowitz Regarding Article, "Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective"Paul M Brown, Justin A Ezekowitz
The Canadian Journal of Cardiology|November 13, 2024
The "Small" Clinical Trial: Methods, Analysis, and Interpretation in Acute Care CardiologyFernando G Zampieri, Justin A Ezekowitz
JACC. Heart Failure|April 30, 2021
Reply: Optimal Positioning of Novel Heart Failure Pharmacotherapies: The Case of VericiguatPaul W Armstrong, Justin A Ezekowitz
Pageof 40